Similar articles

• Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.

  Huber K, De Caterina R, Kristensen SD, Verheugt FW, Montalescot G, Maestro LB, Van de Werf F; Task Force on Pre-hospital Reperfusion Therapy of the Working Group on Thrombosis of the ESC. Huber K, et al. Eur Heart J. 2005 Oct;26(19):2063-74. doi: 10.1093/eurheartj/ehi413. Epub 2005 Jul 29. Eur Heart J. 2005. PMID: 16055497 Review. No abstract available.
• Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.

  Singh S, Gopal AK, Bahl VK. Singh S, et al. Indian Heart J. 2005 May-Jun;57(3):201-9. Indian Heart J. 2005. PMID: 16196176 No abstract available.
• Moving proximally through the intersection between the process and the content of care in ST-elevation myocardial infarction.

  Armstrong PW. Armstrong PW. Eur Heart J. 2005 Oct;26(19):1937-8. doi: 10.1093/eurheartj/ehi462. Epub 2005 Aug 15. Eur Heart J. 2005. PMID: 16103040 No abstract available.
• Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.

  Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ. Dobrzycki S, et al. Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1. Kardiol Pol. 2006. PMID: 16981054 Clinical Trial.
• Percutaneous coronary intervention for acute myocardial infarction: current strategy in the lab.

  Haranath SP, Grines C. Haranath SP, et al. Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B86-98. Indian Heart J. 2007. PMID: 19153441 Review. No abstract available.